Structure‐Guided Engineering of a Cas12i Nuclease Unlocks Near‐PAMless Genome Editing
Advanced Science · 2026
DOI: 10.1002/advs.202516670 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Qitong Chen und 15 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Advanced Biotechnology, Institute of Homeostatic Medicine, and School of Medicine, Southern University of Science and Technology, Shenzh…. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Protein Engineering, CRISPR-Associated Proteins, Gene Editing. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shenzhen Science and Technology Program, Guangdong S&T Program, Shenzhen Science and Technology Innovation Program.
Abstract (Originalsprache)
The therapeutic and research applications of CRISPR‐Cas nucleases are constrained by their reliance on specific Protospacer Adjacent Motifs (PAMs), which limit the accessible sites in the genome. To overcome this critical barrier, we performed structure‐guided engineering of SF01, a compact Cas12i nuclease. Using AlphaFold‐predicted structural models, we identified and systematically mutagenized 38 residues at the PAM‐interacting interface. This iterative engineering process yielded three superior variants—KR, IKRR, and STKRR—that exhibit dramatically relaxed PAM specificity, enabling efficient editing at a broad spectrum of 5'‐NNTN‐3' sites. Importantly, while the most broad‐spectrum variant (STKRR) shows a trade‐off at canonical sites, the IKRR variant retains high activity at canonical 5'‐NTTN‐3' PAMs while simultaneously enabling efficient editing at 5'‐NNTN‐3' sites. This near‐PAMless activity expands the targetable portion of the genome to over 25%, a four‐fold increase over the parental nuclease. Furthermore, adenine base editors (ABEs) constructed with these variants achieve high‐efficiency editing (∼80%) at endogenous loci with expanded targeting scope. Comprehensive off‐target analysis using GUIDE‐tag and Digenome‐seq revealed that the enhanced on‐target activity of the SF01 variants is not accompanied by a loss of specificity. These engineered nucleases represent a powerful and versatile expansion of the genome editing toolkit, enabling applications previously inaccessible due to PAM constraints.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Advanced Biotechnology, Institute of Homeostatic Medicine, and School of Medicine, Southern University of Science and Technology, Shenzhen, China.
- Zhejiang University-University of Edinburgh Institute, Zhejiang University, Hangzhou, China.
ORCID-Profile: Qitong Chen, Hanlin Gou, Pengpeng Liu, Jian-Kang Zhu
Förderung
- Shenzhen Science and Technology Program
- Guangdong S&T Program
- Shenzhen Science and Technology Innovation Program
Zitieren
APA
Chen, Q., Gou, H., Xu, C., Wang, S., Zhang, H., Song, M., Wang, M., Ji, X., Wei, X., Tan, Y., Quan, H., Luo, P., Shou, H., Liu, P., Liang, Y., & Zhu, J. K. (2026). Structure‐Guided Engineering of a Cas12i Nuclease Unlocks Near‐PAMless Genome Editing. Advanced Science. https://doi.org/10.1002/advs.202516670
Vancouver
Chen Q, Gou H, Xu C, Wang S, Zhang H, Song M, et al. Structure‐Guided Engineering of a Cas12i Nuclease Unlocks Near‐PAMless Genome Editing. Advanced Science. 2026. doi:10.1002/advs.202516670
BibTeX
@article{Chen2026,
author = {Chen, Qitong and Gou, Hanlin and Xu, Chao and Wang, Sihan and Zhang, Huitao and Song, Minglei and Wang, Mengge and Ji, Xingkun and Wei, Xiaofei and Tan, Yuanyan and Quan, Hehua and Luo, Pengyu and Shou, Hanyu and Liu, Pengpeng and Liang, Yafeng and Zhu, Jian-Kang},
title = {Structure‐Guided Engineering of a Cas12i Nuclease Unlocks Near‐PAMless Genome Editing},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202516670}
}
EUVIMED